{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T14:52:16Z","timestamp":1780584736892,"version":"3.54.1"},"reference-count":111,"publisher":"XMLink","issue":"47","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["jkms.org"],"crossmark-restriction":false},"short-container-title":["J Korean Med Sci"],"DOI":"10.3346\/jkms.2022.37.e351","type":"journal-article","created":{"date-parts":[[2022,11,30]],"date-time":"2022-11-30T23:48:25Z","timestamp":1669852105000},"update-policy":"https:\/\/doi.org\/10.3346\/crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["COVID-19 Vaccination in Korea: Past, Present, and the Way Forward"],"prefix":"10.3346","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7509-4863","authenticated-orcid":false,"given":"Eliel","family":"Nham","sequence":"first","affiliation":[{"name":"Division of Infectious diseases, Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea."},{"name":"Vaccine Innovation Center-KU Medicine (VIC-K), Seoul, Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0148-7194","authenticated-orcid":false,"given":"Joon Young","family":"Song","sequence":"additional","affiliation":[{"name":"Division of Infectious diseases, Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea."},{"name":"Vaccine Innovation Center-KU Medicine (VIC-K), Seoul, Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8541-5704","authenticated-orcid":false,"given":"Ji Yun","family":"Noh","sequence":"additional","affiliation":[{"name":"Division of Infectious diseases, Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea."},{"name":"Vaccine Innovation Center-KU Medicine (VIC-K), Seoul, Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2532-1463","authenticated-orcid":false,"given":"Hee Jin","family":"Cheong","sequence":"additional","affiliation":[{"name":"Division of Infectious diseases, Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea."},{"name":"Vaccine Innovation Center-KU Medicine (VIC-K), Seoul, Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4546-3880","authenticated-orcid":false,"given":"Woo Joo","family":"Kim","sequence":"additional","affiliation":[{"name":"Division of Infectious diseases, Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea."},{"name":"Vaccine Innovation Center-KU Medicine (VIC-K), Seoul, Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"18617","published-online":{"date-parts":[[2022]]},"reference":[{"issue":"5","key":"10.3346\/jkms.2022.37.e351_ref1","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.3346\/jkms.2020.35.e61","volume":"35","author":"Kim","year":"2020","journal-title":"J Korean Med Sci"},{"key":"10.3346\/jkms.2022.37.e351_ref2","unstructured":"WHO. Coronavirus disease (COVID-19) pandemic. Updated September 29, 2022. Accessed September 29, 2022.  https:\/\/www.who.int\/europe\/emergencies\/situations\/covid-19"},{"key":"10.3346\/jkms.2022.37.e351_ref3","unstructured":"Cumulative confirmed COVID-19 deaths. Updated September 28, 2022. Accessed September 29, 2022.  https:\/\/ourworldindata.org\/coronavirus#explore-the-global-situation"},{"issue":"2","key":"10.3346\/jkms.2022.37.e351_ref4","doi-asserted-by":"crossref","first-page":"85","DOI":"10.24171\/j.phrp.2020.11.2.05","volume":"11","author":"COVID-19 National Emergency Response Center, Epidemiology and Case Management Team, Korea Centers for Disease Control and Prevention","year":"2020","journal-title":"Osong Public Health Res Perspect"},{"issue":"2","key":"10.3346\/jkms.2022.37.e351_ref5","doi-asserted-by":"crossref","first-page":"154","DOI":"10.3947\/ic.2020.52.2.154","volume":"52","author":"Kang","year":"2020","journal-title":"Infect Chemother"},{"issue":"4","key":"10.3346\/jkms.2022.37.e351_ref6","doi-asserted-by":"crossref","first-page":"718","DOI":"10.3947\/ic.2021.0104","volume":"53","author":"Kim","year":"2021","journal-title":"Infect Chemother"},{"issue":"2","key":"10.3346\/jkms.2022.37.e351_ref7","doi-asserted-by":"crossref","first-page":"319","DOI":"10.3947\/ic.2021.0026","volume":"53","author":"Agca","year":"2021","journal-title":"Infect Chemother"},{"issue":"1","key":"10.3346\/jkms.2022.37.e351_ref8","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3947\/ic.2020.0136","volume":"53","author":"Hoang","year":"2021","journal-title":"Infect Chemother"},{"issue":"3","key":"10.3346\/jkms.2022.37.e351_ref9","doi-asserted-by":"crossref","first-page":"463","DOI":"10.3947\/ic.2021.0022","volume":"53","author":"Kim","year":"2021","journal-title":"Infect Chemother"},{"issue":"3","key":"10.3346\/jkms.2022.37.e351_ref10","doi-asserted-by":"crossref","first-page":"566","DOI":"10.3947\/ic.2022.0141","volume":"54","author":"Kim","year":"2022","journal-title":"Infect Chemother"},{"key":"10.3346\/jkms.2022.37.e351_ref11","unstructured":"KDCA. COVID-19 vaccination safety report. Updated September 25, 2022. Accessed September 29, 2022.  https:\/\/ncv.kdca.go.kr\/board.es?mid=a11707010000&bid=0032#"},{"issue":"4","key":"10.3346\/jkms.2022.37.e351_ref12","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrd.2017.243","volume":"17","author":"Pardi","year":"2018","journal-title":"Nat Rev Drug Discov"},{"issue":"27","key":"10.3346\/jkms.2022.37.e351_ref13","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","volume":"383","author":"Polack","year":"2020","journal-title":"N Engl J Med"},{"issue":"5","key":"10.3346\/jkms.2022.37.e351_ref14","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJMoa2035389","volume":"384","author":"Baden","year":"2021","journal-title":"N Engl J Med"},{"issue":"16","key":"10.3346\/jkms.2022.37.e351_ref15","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1016\/j.vaccine.2021.03.038","volume":"39","author":"Rosa","year":"2021","journal-title":"Vaccine"},{"key":"10.3346\/jkms.2022.37.e351_ref16","doi-asserted-by":"crossref","first-page":"e069445","DOI":"10.1136\/bmj-2021-069445","volume":"378","author":"Pillay","year":"2022","journal-title":"BMJ"},{"issue":"2","key":"10.3346\/jkms.2022.37.e351_ref17","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/s41569-021-00662-w","volume":"19","author":"Heymans","year":"2022","journal-title":"Nat Rev Cardiol"},{"key":"10.3346\/jkms.2022.37.e351_ref18","unstructured":"CDC. Update on myocarditis following mRNA COVID-19 vaccination. Updated June 7, 2022. Accessed September 15, 2022.  https:\/\/www.fda.gov\/media\/159007\/download"},{"key":"10.3346\/jkms.2022.37.e351_ref19","unstructured":"EMA. New vaccine for prevention of Ebola virus disease recommended for approval in the European Union. Updated May 29, 2020. Accessed September 15, 2022.  https:\/\/www.ema.europa.eu\/en\/documents\/press-release\/new-vaccine-prevention-ebola-virus-disease-recommended-approval-european-union_en.pdf"},{"key":"10.3346\/jkms.2022.37.e351_ref20","unstructured":"WHO. Ebola virus disease - Democratic Republic of Congo External Situation Report 98. Updated June 23, 2020. Accessed September 15, 2022.  https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/332654\/SITREP_EVD_DRC_20200623-eng.pdf"},{"issue":"3","key":"10.3346\/jkms.2022.37.e351_ref21","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1586\/14760584.6.3.347","volume":"6","author":"Yang","year":"2007","journal-title":"Expert Rev Vaccines"},{"issue":"10","key":"10.3346\/jkms.2022.37.e351_ref22","doi-asserted-by":"crossref","first-page":"2875","DOI":"10.4161\/hv.29594","volume":"10","author":"Fausther-Bovendo","year":"2014","journal-title":"Hum Vaccin Immunother"},{"issue":"10303","key":"10.3346\/jkms.2022.37.e351_ref23","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/S0140-6736(21)01694-9","volume":"398","author":"Liu","year":"2021","journal-title":"Lancet"},{"key":"10.3346\/jkms.2022.37.e351_ref24","doi-asserted-by":"crossref","first-page":"100501","DOI":"10.1016\/j.lanepe.2022.100501","volume":"22","author":"Vivaldi","year":"2022","journal-title":"Lancet Reg Health Eur"},{"issue":"7","key":"10.3346\/jkms.2022.37.e351_ref25","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/S1473-3099(22)00146-3","volume":"22","author":"Menni","year":"2022","journal-title":"Lancet Infect Dis"},{"issue":"18","key":"10.3346\/jkms.2022.37.e351_ref26","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1056\/NEJMoa2109908","volume":"385","author":"Pavord","year":"2021","journal-title":"N Engl J Med"},{"issue":"1","key":"10.3346\/jkms.2022.37.e351_ref27","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s40794-022-00176-4","volume":"8","author":"Acosta-Coley","year":"2022","journal-title":"Trop Dis Travel Med Vaccines"},{"issue":"6","key":"10.3346\/jkms.2022.37.e351_ref28","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1056\/NEJMoa2116185","volume":"386","author":"Dunkle","year":"2022","journal-title":"N Engl J Med"},{"issue":"13","key":"10.3346\/jkms.2022.37.e351_ref29","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1056\/NEJMoa2107659","volume":"385","author":"Heath","year":"2021","journal-title":"N Engl J Med"},{"key":"10.3346\/jkms.2022.37.e351_ref30","volume-title":"Phase 3 Study of Safety and Immunogenicity of GBP510 Vaccine Adjuvanted With AS03 in Adults (Abstract Number: 828), International Congress on Infectious Diseases (ISID 2022)","author":"Song","year":"2022"},{"issue":"1","key":"10.3346\/jkms.2022.37.e351_ref31","doi-asserted-by":"crossref","first-page":"140","DOI":"10.3947\/ic.2022.0009","volume":"54","author":"Lim","year":"2022","journal-title":"Infect Chemother"},{"issue":"46","key":"10.3346\/jkms.2022.37.e351_ref32","doi-asserted-by":"crossref","first-page":"e311","DOI":"10.3346\/jkms.2021.36.e311","volume":"36","author":"Kang","year":"2021","journal-title":"J Korean Med Sci"},{"issue":"5","key":"10.3346\/jkms.2022.37.e351_ref33","doi-asserted-by":"crossref","first-page":"946","DOI":"10.3390\/v14050946","volume":"14","author":"Lee","year":"2022","journal-title":"Viruses"},{"issue":"27","key":"10.3346\/jkms.2022.37.e351_ref34","doi-asserted-by":"crossref","first-page":"e210","DOI":"10.3346\/jkms.2022.37.e210","volume":"37","author":"Hyun","year":"2022","journal-title":"J Korean Med Sci"},{"issue":"10","key":"10.3346\/jkms.2022.37.e351_ref35","doi-asserted-by":"crossref","first-page":"1390.e1","DOI":"10.1016\/j.cmi.2022.04.019","volume":"28","author":"Bae","year":"2022","journal-title":"Clin Microbiol Infect"},{"issue":"11","key":"10.3346\/jkms.2022.37.e351_ref36","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/S2213-2600(21)00357-X","volume":"9","author":"Hillus","year":"2021","journal-title":"Lancet Respir Med"},{"key":"10.3346\/jkms.2022.37.e351_ref37","unstructured":"KDCA. Analysis of the preventive effect of the fourth coronavirus disease vaccine dose in immunocompromised individuals and residents of elderly care hospitals and facilities. Updated July 14, 2022. Accessed September 17, 2022.  https:\/\/kdca.go.kr\/board\/board.es?mid=a20602010000&bid=0034&list_no=720134&act=view"},{"key":"10.3346\/jkms.2022.37.e351_ref38","unstructured":"KDCA. A fourth COVID-19 vaccination in 60+. Updated April 13, 2022. Accessed October 1, 2022.  http:\/\/ncov.kdca.go.kr\/tcmBoardView.do?brdId=3&brdGubun=31&dataGubun=&ncvContSeq=6567&contSeq=6567&board_id=312&gubun=BDJ"},{"issue":"1","key":"10.3346\/jkms.2022.37.e351_ref39","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1186\/s12916-022-02383-4","volume":"20","author":"Kang","year":"2022","journal-title":"BMC Med"},{"key":"10.3346\/jkms.2022.37.e351_ref40","author":"Choi","year":"2022","journal-title":"J Infect"},{"issue":"5","key":"10.3346\/jkms.2022.37.e351_ref41","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.jinf.2022.07.024","volume":"85","author":"Noh","year":"2022","journal-title":"J Infect"},{"issue":"6","key":"10.3346\/jkms.2022.37.e351_ref42","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1038\/s41591-021-01325-6","volume":"27","author":"Ebinger","year":"2021","journal-title":"Nat Med"},{"issue":"14","key":"10.3346\/jkms.2022.37.e351_ref43","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1056\/NEJMc2101667","volume":"384","author":"Krammer","year":"2021","journal-title":"N Engl J Med"},{"issue":"26","key":"10.3346\/jkms.2022.37.e351_ref44","doi-asserted-by":"crossref","first-page":"3670","DOI":"10.1016\/j.vaccine.2022.05.002","volume":"40","author":"Yi","year":"2022","journal-title":"Vaccine"},{"issue":"2","key":"10.3346\/jkms.2022.37.e351_ref45","doi-asserted-by":"crossref","first-page":"114","DOI":"10.24171\/j.phrp.2021.0262","volume":"13","author":"Kim","year":"2022","journal-title":"Osong Public Health Res Perspect"},{"key":"10.3346\/jkms.2022.37.e351_ref46","unstructured":"KDCA. A Korea COVID-19 vaccine effectiveness (K-COVE) study published on clinical infectious diseases. Updated 2022. Accessed September 17, 2022.  https:\/\/www.korea.kr\/news\/pressReleaseView.do?newsId=156504574"},{"key":"10.3346\/jkms.2022.37.e351_ref47","unstructured":"KDCA. COV-EPI evaluation study in LTCF. Updated May 12, 2022. Accessed September 17, 2022.  https:\/\/kdca.go.kr\/board\/board.es?mid=a20602010000&bid=0034&list_no=719529&act=view"},{"issue":"4","key":"10.3346\/jkms.2022.37.e351_ref48","doi-asserted-by":"crossref","first-page":"139","DOI":"10.15585\/mmwr.mm7104e3","volume":"71","author":"Thompson","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"9","key":"10.3346\/jkms.2022.37.e351_ref49","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.3390\/vaccines10091396","volume":"10","author":"Zhu","year":"2022","journal-title":"Vaccines (Basel)"},{"issue":"35","key":"10.3346\/jkms.2022.37.e351_ref50","doi-asserted-by":"crossref","first-page":"e267","DOI":"10.3346\/jkms.2022.37.e267","volume":"37","author":"Kim","year":"2022","journal-title":"J Korean Med Sci"},{"key":"10.3346\/jkms.2022.37.e351_ref51","doi-asserted-by":"crossref","first-page":"e071502","DOI":"10.1136\/bmj-2022-071502","volume":"378","author":"Grewal","year":"2022","journal-title":"BMJ"},{"key":"10.3346\/jkms.2022.37.e351_ref52","doi-asserted-by":"crossref","first-page":"100466","DOI":"10.1016\/j.lanepe.2022.100466","volume":"21","author":"Nordstr\u00f6m","year":"2022","journal-title":"Lancet Reg Health Eur"},{"issue":"5","key":"10.3346\/jkms.2022.37.e351_ref53","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.vaccine.2021.12.044","volume":"40","author":"June Choe","year":"2022","journal-title":"Vaccine"},{"issue":"1","key":"10.3346\/jkms.2022.37.e351_ref54","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1056\/NEJMc2206576","volume":"387","author":"Hachmann","year":"2022","journal-title":"N Engl J Med"},{"key":"10.3346\/jkms.2022.37.e351_ref55","author":"Tseng","journal-title":"medRxiv"},{"key":"10.3346\/jkms.2022.37.e351_ref56","doi-asserted-by":"crossref","first-page":"100537","DOI":"10.1016\/j.lanepe.2022.100537","volume":"23","author":"M\u00f8ller Kirsebom","year":"2022","journal-title":"Lancet Reg Health Eur"},{"issue":"42","key":"10.3346\/jkms.2022.37.e351_ref57","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.15585\/mmwr.mm7142a3","volume":"71","author":"Surie","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"12","key":"10.3346\/jkms.2022.37.e351_ref58","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1016\/S1473-3099(22)00692-2","volume":"22","author":"Tartof","year":"2022","journal-title":"Lancet Infect Dis"},{"issue":"14","key":"10.3346\/jkms.2022.37.e351_ref59","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1056\/NEJMc2210093","volume":"387","author":"Collie","year":"2022","journal-title":"N Engl J Med"},{"key":"10.3346\/jkms.2022.37.e351_ref60","unstructured":"Pfizer-BioNTech. Pfizer and BioNTech announce omicron-adapted COVID-19 vaccine candidates demonstrate high immune response against omicron. Updated June 25, 2022. Accessed November 16, 2022.  https:\/\/www.pfizer.com\/news\/press-release\/press-release-detail\/pfizer-and-biontech-announce-omicron-adapted-covid-19"},{"key":"10.3346\/jkms.2022.37.e351_ref61","unstructured":"Moderna. Moderna\u2019s BA.4\/BA.5 targeting bivalent booster, mRNA-1273.222, meets primary endpoint of superiority against omicron variants compared to booster dose of mRNA-1273 in phase 2\/3 clinical trial. Updated November 14, 2022. Accessed November 16, 2022.  https:\/\/investors.modernatx.com\/news\/news-details\/2022\/Modernas-BA.4BA.5-Targeting-Bivalent-Booster-mRNA-1273.222-Meets-Primary-Endpoint-of-Superiority-Against-Omicron-Variants-Compared-to-Booster-Dose-of-mRNA-1273-in-Phase-23-Clinical-Trial\/default.aspx#"},{"key":"10.3346\/jkms.2022.37.e351_ref62","unstructured":"Pfizer-BioNTech. Pfizer\/BioNTech COVID-19 omicron-modified bivalent vaccine. Updated September 1, 2022. Accessed November 16, 2022.  https:\/\/www.cdc.gov\/vaccines\/acip\/meetings\/downloads\/slides-2022-09-01\/07-covid-swanson-508.pdf"},{"key":"10.3346\/jkms.2022.37.e351_ref63","author":"Scheaffer","journal-title":"Nat Med"},{"key":"10.3346\/jkms.2022.37.e351_ref64","author":"Collier","journal-title":"bioRxiv"},{"key":"10.3346\/jkms.2022.37.e351_ref65","doi-asserted-by":"crossref","unstructured":"Effectiveness of bivalent mRNA vaccines in preventing symptomatic SARS-CoV-2 infection \u2014 increasing community access to testing program, United States, September\u2013November 2022. Updated 2022. Accessed November 23, 2022.  https:\/\/www.cdc.gov\/mmwr\/volumes\/71\/wr\/mm7148e1.htm","DOI":"10.15585\/mmwr.mm7148e1"},{"issue":"34","key":"10.3346\/jkms.2022.37.e351_ref66","doi-asserted-by":"crossref","first-page":"e245","DOI":"10.3346\/jkms.2021.36.e245","volume":"36","author":"Hyun","year":"2021","journal-title":"J Korean Med Sci"},{"issue":"3","key":"10.3346\/jkms.2022.37.e351_ref67","doi-asserted-by":"crossref","first-page":"559","DOI":"10.3947\/ic.2021.0072","volume":"54","author":"Lee","year":"2022","journal-title":"Infect Chemother"},{"issue":"45","key":"10.3346\/jkms.2022.37.e351_ref68","doi-asserted-by":"crossref","first-page":"e312","DOI":"10.3346\/jkms.2021.36.e312","volume":"36","author":"Park","year":"2021","journal-title":"J Korean Med Sci"},{"issue":"1","key":"10.3346\/jkms.2022.37.e351_ref69","doi-asserted-by":"crossref","first-page":"189","DOI":"10.3947\/ic.2021.0131","volume":"54","author":"Kang","year":"2022","journal-title":"Infect Chemother"},{"issue":"23","key":"10.3346\/jkms.2022.37.e351_ref70","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1056\/NEJMoa2101544","volume":"384","author":"Sadoff","year":"2021","journal-title":"N Engl J Med"},{"issue":"6","key":"10.3346\/jkms.2022.37.e351_ref71","doi-asserted-by":"crossref","first-page":"396","DOI":"10.24171\/j.phrp.2021.0310","volume":"12","author":"Hwang","year":"2021","journal-title":"Osong Public Health Res Perspect"},{"issue":"2","key":"10.3346\/jkms.2022.37.e351_ref72","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.vaccine.2021.11.066","volume":"40","author":"Maltezou","year":"2022","journal-title":"Vaccine"},{"issue":"3","key":"10.3346\/jkms.2022.37.e351_ref73","doi-asserted-by":"crossref","first-page":"557","DOI":"10.3947\/ic.2021.0044","volume":"53","author":"Song","year":"2021","journal-title":"Infect Chemother"},{"issue":"17","key":"10.3346\/jkms.2022.37.e351_ref74","doi-asserted-by":"crossref","first-page":"e114","DOI":"10.3346\/jkms.2021.36.e114","volume":"36","author":"Jeon","year":"2021","journal-title":"J Korean Med Sci"},{"issue":"17","key":"10.3346\/jkms.2022.37.e351_ref75","doi-asserted-by":"crossref","first-page":"e115","DOI":"10.3346\/jkms.2021.36.e115","volume":"36","author":"Bae","year":"2021","journal-title":"J Korean Med Sci"},{"issue":"14","key":"10.3346\/jkms.2022.37.e351_ref76","doi-asserted-by":"crossref","first-page":"e107","DOI":"10.3346\/jkms.2021.36.e107","volume":"36","author":"Kim","year":"2021","journal-title":"J Korean Med Sci"},{"issue":"21","key":"10.3346\/jkms.2022.37.e351_ref77","doi-asserted-by":"crossref","first-page":"e153","DOI":"10.3346\/jkms.2021.36.e153","volume":"36","author":"Lee","year":"2021","journal-title":"J Korean Med Sci"},{"issue":"3","key":"10.3346\/jkms.2022.37.e351_ref78","doi-asserted-by":"crossref","first-page":"230","DOI":"10.24171\/j.phrp.2022.0122","volume":"13","author":"Kim","year":"2022","journal-title":"Osong Public Health Res Perspect"},{"issue":"3","key":"10.3346\/jkms.2022.37.e351_ref79","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1056\/NEJMoa2107456","volume":"385","author":"Frenck","year":"2021","journal-title":"N Engl J Med"},{"issue":"31","key":"10.3346\/jkms.2022.37.e351_ref80","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.15585\/mmwr.mm7031e1","volume":"70","author":"Hause","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"5","key":"10.3346\/jkms.2022.37.e351_ref81","doi-asserted-by":"crossref","first-page":"744","DOI":"10.3390\/vaccines10050744","volume":"10","author":"Lee","year":"2022","journal-title":"Vaccines (Basel)"},{"issue":"37","key":"10.3346\/jkms.2022.37.e351_ref82","doi-asserted-by":"crossref","first-page":"5544","DOI":"10.1016\/j.vaccine.2018.05.119","volume":"37","author":"Principi","year":"2019","journal-title":"Vaccine"},{"issue":"9876","key":"10.3346\/jkms.2022.37.e351_ref83","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1016\/S0140-6736(12)62189-8","volume":"381","author":"Salmon","year":"2013","journal-title":"Lancet"},{"key":"10.3346\/jkms.2022.37.e351_ref84","unstructured":"Coronavirus vaccine - summary of Yellow Card reporting. Updated September 1, 2022. Accessed September 25, 2022.  https:\/\/www.gov.uk\/government\/publications\/coronavirus-covid-19-vaccine-adverse-reactions\/coronavirus-vaccine-summary-of-yellow-card-reporting"},{"key":"10.3346\/jkms.2022.37.e351_ref85","unstructured":"Reported side effects following COVID-19 vaccination in Canada. Updated September 2, 2022. Accessed September 25, 2022.  https:\/\/health-infobase.canada.ca\/covid-19\/vaccine-safety\/"},{"issue":"4","key":"10.3346\/jkms.2022.37.e351_ref86","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1001\/jama.2021.24110","volume":"327","author":"Oster","year":"2022","journal-title":"JAMA"},{"key":"10.3346\/jkms.2022.37.e351_ref87","unstructured":"KDCA. National Vaccine Injury Compensation Program. Updated 2022. Accessed November 16, 2022.  https:\/\/ncv.kdca.go.kr\/menu.es?mid=a12602000000"},{"issue":"39","key":"10.3346\/jkms.2022.37.e351_ref88","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.56786\/PHWR.2022.15.39.2653","volume":"15","author":"Kim","year":"2022","journal-title":"Public Health Wkly Rep"},{"key":"10.3346\/jkms.2022.37.e351_ref89","unstructured":"KDCA. Strengthening goverment support for vaccine injury compensation. Updated July 19, 2022. Accessed November 16, 2022.  https:\/\/ncov.kdca.go.kr\/tcmBoardView.do?brdId=3&brdGubun=31&dataGubun=&ncvContSeq=6763&contSeq=6763&board_id=312&gubun=BDJ"},{"issue":"2","key":"10.3346\/jkms.2022.37.e351_ref90","doi-asserted-by":"crossref","first-page":"261","DOI":"10.3947\/ic.2021.0029","volume":"53","author":"Noh","year":"2021","journal-title":"Infect Chemother"},{"issue":"22","key":"10.3346\/jkms.2022.37.e351_ref91","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1056\/NEJMoa2104882","volume":"384","author":"Schultz","year":"2021","journal-title":"N Engl J Med"},{"issue":"22","key":"10.3346\/jkms.2022.37.e351_ref92","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1056\/NEJMoa2104840","volume":"384","author":"Greinacher","year":"2021","journal-title":"N Engl J Med"},{"issue":"22","key":"10.3346\/jkms.2022.37.e351_ref93","doi-asserted-by":"crossref","first-page":"e175","DOI":"10.3346\/jkms.2022.37.e175","volume":"37","author":"Shi","year":"2022","journal-title":"J Korean Med Sci"},{"issue":"7898","key":"10.3346\/jkms.2022.37.e351_ref94","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/s41586-021-04388-0","volume":"602","author":"Liu","year":"2022","journal-title":"Nature"},{"key":"10.3346\/jkms.2022.37.e351_ref95","unstructured":"Cumulative confirmed COVID-19 cases per million people. Updated September 29, 2022. Accessed September 30, 2022.  https:\/\/ourworldindata.org\/coronavirus#explore-the-global-situation"},{"key":"10.3346\/jkms.2022.37.e351_ref96","unstructured":"Excess mortality: Deaths from all causes compared to average over previous years. Updated July 31, 2022. Accessed October 1, 2022.  https:\/\/ourworldindata.org\/grapher\/excess-mortality-p-scores-average-baseline?country=~KOR"},{"key":"10.3346\/jkms.2022.37.e351_ref97","unstructured":"KDCA. Current status of COVID-19 outbreak and vaccination in Korea. Updated September 29, 2022. Accessed September 30, 2022.  http:\/\/ncov.kdca.go.kr\/tcmBoardView.do?brdId=3&brdGubun=31&dataGubun=&ncvContSeq=6897&contSeq=6897&board_id=312&gubun=BDJ"},{"key":"10.3346\/jkms.2022.37.e351_ref98","unstructured":"KDCA. Booster plans against COVID-19, Winter 2022\u20132023: press release. Updated September 21, 2022. Accessed September 30, 2022.  http:\/\/ncov.kdca.go.kr\/tcmBoardView.do?brdId=3&brdGubun=31&dataGubun=&ncvContSeq=6850&contSeq=6850&board_id=312&gubun=BDJ"},{"issue":"1","key":"10.3346\/jkms.2022.37.e351_ref99","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41577-021-00657-1","volume":"22","author":"Laidlaw","year":"2022","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"10.3346\/jkms.2022.37.e351_ref100","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/s41590-021-01122-w","volume":"23","author":"Moss","year":"2022","journal-title":"Nat Immunol"},{"issue":"8","key":"10.3346\/jkms.2022.37.e351_ref101","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1038\/s41564-022-01166-0","volume":"7","author":"H\u00e4gg","year":"2022","journal-title":"Nat Microbiol"},{"issue":"4","key":"10.3346\/jkms.2022.37.e351_ref102","doi-asserted-by":"crossref","first-page":"753","DOI":"10.3947\/ic.2021.0122","volume":"53","author":"Duong","year":"2021","journal-title":"Infect Chemother"},{"issue":"4","key":"10.3346\/jkms.2022.37.e351_ref103","doi-asserted-by":"crossref","first-page":"676","DOI":"10.3947\/ic.2021.0134","volume":"53","author":"Lamptey","year":"2021","journal-title":"Infect Chemother"},{"issue":"1","key":"10.3346\/jkms.2022.37.e351_ref104","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3947\/ic.2021.0302","volume":"53","author":"Choi","year":"2021","journal-title":"Infect Chemother"},{"key":"10.3346\/jkms.2022.37.e351_ref105","unstructured":"MFDS. Domestic COVID-19 vaccine candidates in clinical trials. Updated November 1, 2022. Accessed November 18, 2022.  https:\/\/www.mfds.go.kr\/docviewer\/skin\/doc.html?fn=20220805094804221.png&rs=\/docviewer\/result\/co19vaccine01\/1\/1\/202211"},{"key":"10.3346\/jkms.2022.37.e351_ref106","unstructured":"Novavax and SK bioscience Expand Manufacturing Agreement. Updated December 23, 2021. Accessed November 18, 2022.  https:\/\/ir.novavax.com\/2021-12-23-Novavax-and-SK-bioscience-Expand-Manufacturing-Agreement"},{"key":"10.3346\/jkms.2022.37.e351_ref107","unstructured":"Moderna and Samsung Biologics Announce Agreement for Fill-Finish Manufacturing of Moderna\u2019s COVID-19 Vaccine. Updated August 13, 2021. Accessed November 18, 2022.  https:\/\/samsungbiologics.com\/kr\/media\/company-news-view?boardSeq=1207&schBoardCtgryCcd=1&schString=&schBoardYear=&boardDtm=1621699200000&page=2"},{"key":"10.3346\/jkms.2022.37.e351_ref108","unstructured":"IVI. IVI to operate training courses for WHO global biomanufacturing training hub in Republic of Korea. Updated March 29, 2022. Accessed November 18, 2022.  https:\/\/www.ivi.int\/ivi-to-operate-training-courses-for-who-global-biomanufacturing-training-hub-in-republic-of-korea\/"},{"issue":"1","key":"10.3346\/jkms.2022.37.e351_ref109","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3947\/ic.2021.0301","volume":"53","author":"Peck","year":"2021","journal-title":"Infect Chemother"},{"key":"10.3346\/jkms.2022.37.e351_ref110","unstructured":"Ministry of Food and Drug Safety. COVID-19 vaccines. Updated November 1, 2022. Accessed November 14, 2022.  https:\/\/www.mfds.go.kr\/docviewer\/skin\/doc.html?fn=20221101084746428.hwp&rs=\/docviewer\/result\/co19vaccine01\/5\/1\/202211"},{"issue":"25","key":"10.3346\/jkms.2022.37.e351_ref111","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1056\/NEJMoa2105290","volume":"385","author":"Falsey","year":"2021","journal-title":"N Engl J Med"}],"container-title":["Journal of Korean Medical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jkms.org\/pdf\/10.3346\/jkms.2022.37.e351","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/jkms.org\/DOIx.php?id=10.3346\/jkms.2022.37.e351","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/jkms.org\/DOIx.php?id=10.3346\/jkms.2022.37.e351","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,4]],"date-time":"2022-12-04T23:51:52Z","timestamp":1670197912000},"score":1,"resource":{"primary":{"URL":"https:\/\/jkms.org\/DOIx.php?id=10.3346\/jkms.2022.37.e351"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"references-count":111,"journal-issue":{"issue":"47","published-online":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.3346\/jkms.2022.37.e351","relation":{},"ISSN":["1011-8934","1598-6357"],"issn-type":[{"value":"1011-8934","type":"print"},{"value":"1598-6357","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022]]},"assertion":[{"value":"2022-11-05","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-11-28","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-11-30","name":"published_online","label":"Published online","group":{"name":"publication_history","label":"Publication History"}},{"value":"\u00a9 2022 The Korean Academy of Medical Sciences.","name":"copyright","label":"Copyright","group":{"name":"Copyright_and_licensing","label":"Copyright and Licensing"}},{"value":"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.","name":"license","label":"License","explanation":{"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},"group":{"name":"Copyright_and_licensing","label":"Copyright and Licensing"}}],"article-number":"e351"}}